Anti-CCP antibodies and bone. [PDF]
Arthritis Res Ther, 2018 Anti-CCP antibodies and bone.
Orsolini G +6 more
europepmc +8 more sources
Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays. [PDF]
Sci Rep, 2021 AbstractThe presence or absence of autoantibodies against citrullinated proteins (ACPAs) distinguishes two main groups of rheumatoid arthritis (RA) patients with different etiologies, prognoses, disease severities, and, presumably, disease pathogenesis.
Poulsen TBG +6 more
europepmc +8 more sources
Anti‐CCP: History and its Usefulness [PDF]
Journal of Immunology Research, 2005 Antibodies directed to cyclic citrullinated peptides (anti‐CCP) are highly specific for rheumatoid arthritis (RA) and can easily be detected in sera by using commercially available immunoassays. The second version of the anti‐CCP test (anti‐CCP2) demonstrated high specificity (89‐98%) and good sensitivity (41‐88%)
M. Herold, V. Boeser, E. Russe, W. Klotz
openaire +5 more sources
Prevalence of anti-CCP antibodies in systemic sclerosis
Reumatismo, 2011 Joint involvement in systemic sclerosis (SSc) commonly occurs as arthralgias, while a true arthritis is less frequent. The most common arthritis developing in SSc is rheumatoid arthritis (RA) and its diagnosis may be misled by concomitant joint contracture or tendon sheath involvement due to SSc.
MARRONE M +8 more
openaire +7 more sources
Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood [PDF]
International Journal of Rheumatology, 2013 Objective. Anticyclic citrullinated peptide antibodies (anti-CCP) testing is useful in the diagnosis of rheumatoid arthritis (RA) with high specificity. Arthritis is a very common clinical manifestation in children with familial Mediterranean fever (FMF).
Onur H. +5 more
core +8 more sources
Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients [PDF]
Indian Journal of Medical Sciences, 2009 The usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP antibodies) to identify rheumatic arthritis (RA) from other rheumatic diseases presenting with joint pain is not well studied.We aimed to determine the sensitivity and specificity of anti-CCP antibodies in Indian RA patients with respect to non-RA rheumatic diseases and to study ...
Gupta, R. +5 more
core +6 more sources
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis [PDF]
Rheumatology International, 2008 Antibodies to citrullinated proteins have been described in patients with rheumatoid arthritis (RA) and these appear to be the most specific markers of the disease. Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in patients with RA and the association of anti-CCP antibodies with disease activity ...
Sibel Kul +2 more
exaly +3 more sources
Possible Role of Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Rheumatic Diseases [PDF]
Diyala Journal of Medicine, 2019 Background: Anti-cyclic citrullinated peptide (anti-CCP) antibodies are highly specific for RA, but are not detectable in all RA patients, in addition their usefulness to identify rheumatic arthritis (RA) from other rheumatic diseases presenting with ...
Eman Sh Al-Obeidy +2 more
doaj +3 more sources
The influence of polygenic risk scores on heritability of anti-CCP level in RA [PDF]
Genes & Immunity, 2014 The objective of this study was to study genetic factors that influence quantitative anticyclic citrullinated peptide (anti-CCP) antibody levels in RA patients. We carried out a genome-wide association study (GWAS) meta-analysis using 1975 anti-CCP+ RA patients from three large cohorts, the Brigham Rheumatoid Arthritis Sequential Study (BRASS), North ...
Cui, Jing +11 more
openaire +6 more sources
Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays. [PDF]
Clin Rheumatol, 2017 This study compares the diagnostic performance of a second generation anti-cyclic citrullinated peptide antibody (CCP2) with a third generation anti-CCP antibodies assay (CCP3), as well as the combination of both tests. Serum samples of 127 patients were analyzed.
Vos I +7 more
europepmc +6 more sources